Invention of circRNA promoting RNA to specifically promote circRNA production
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Zhilin He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China. Hauptthemen laut MEDLINE: RNA, Circular, Cell Proliferation. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China, Hunan Provincial Natural Science Foundation for Distinguished Young Scholars.
Abstract (Originalsprache)
CircRNA, an essential RNA molecule involved in various biological functions and diseases, often exhibits decreased expression in tumor tissues, playing a role as a tumor suppressor, and suggesting therapeutic potential for cancer. However, current methods for promoting circRNA production are limited. This study introduces a novel approach for enhancing circRNA biogenesis, termed circRNA promoting RNA (cpRNA). CpRNA is designed to complement the flanking sequences of reverse complementary matches (RCMs) within pre-mRNA, thereby facilitating circRNA formation through improved exon circularization. Using a split-GFP reporter system, we demonstrated that cpRNA significantly enhance circGFP production. Optimization identified the best conditions for cpRNA to promote circRNA biogenesis, and these cpRNAs were then used to augment the production of endogenous circRNAs. These results indicate that cpRNAs can specifically increase the production of endogenous circRNAs with RCMs, such as circZKSCAN1 and circSMARCA5 in cancer cells, thereby inhibiting cell proliferation and migration by modulating circRNA-related pathways, showcasing the therapeutic potential of cpRNAs. Mechanistic studies have also shown that cpRNA promotes circRNA biogenesis, in part, by antagonizing the unwinding function of DHX9. Overall, these findings suggest that cpRNA represents a promising strategy for circRNA overexpression, offering a potential treatment for diseases marked by low circRNA levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
ORCID-Profile: Qubo Zhu
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation for Distinguished Young Scholars
Zitieren
APA
He, Z., Ji, H., Xia, B., Cao, X., Huang, Y., & Zhu, Q. (2024). Invention of circRNA promoting RNA to specifically promote circRNA production. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae693
Vancouver
He Z, Ji H, Xia B, Cao X, Huang Y, Zhu Q. Invention of circRNA promoting RNA to specifically promote circRNA production. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae693
BibTeX
@article{He2024,
author = {He, Zhilin and Ji, Haofei and Xia, Bei and Cao, Xiuen and Huang, Ying and Zhu, Qubo},
title = {Invention of circRNA promoting RNA to specifically promote circRNA production},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae693}
}
EUVIMED